KYNB · ISSUER CIK 921299
KYNTRA BIO, INC.
Between Aug 1, 2026 and Oct 29, 2026, 2 KYNTRA BIO, INC. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 9, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 202620:42 | Sep 6, 2026 | KYNB | CEO, Director | F · Tax | $8.55 | −209 | 26,796 | -1% | $2K | ||
| Sep 9, 202620:41 | Sep 6, 2026 | KYNB | Chief Financial Officer | F · Tax | $8.55 | −22 | 4,355 | -1% | $188.10 |